Rüdiger Klein (born March 24, 1958, in Nickenich) is a German neurobiologist.
Rüdiger Klein studied biology at the universities of Marburg and Tübingen and at the Juniata College (USA).
He gained his PhD at the University of Tübingen and worked as a post-doctoral researcher at the National Cancer Institute at Frederick (NCI-Frederick) (USA) and at the Bristol-Myers Squibb Pharmaceutical Research Institute (USA).
Afterwards, he led a junior research group at the European Molecular Biology Laboratory (EMBL) in Heidelberg.
Rüdiger Klein’s scientific research is focused on the molecular mechanisms which allow nerve cells to communicate.